Top Markets
Coin of the day
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited

4582
Rangering i aksjer #28751
SymBio Pharmaceuticals Limited engages in the and development, manufacturing... SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Aksjekurs
$0.45018154
Markedsverdi
$24.81M
Endring (1 dag)
1.47%
Endring (1 år)
-56.57%
Land
JP
Handel SymBio Pharmaceuticals Limited (4582)

Kategori

P/S-forhold for SymBio Pharmaceuticals Limited (4582)
P/S-forhold per 2026 TTM: 0
Ifølge SymBio Pharmaceuticals Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for SymBio Pharmaceuticals Limited fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter